WT1 was originally discovered as a tumor suppressor because of its loss-of-function mutations in a subset of pediatric renal neoplasms, known as nephroblastomas or Wilms’ tumors (Huff et al., 1991). This evidence concerns the gene WT1 and Wilms tumor.